Drug slows the progression of type 1 diabetes in children and adolescents
A Yale-led trial finds that the drug teplizumab helps preserve the ability of children and adolescents with new-onset type 1 diabetes to make their own insulin.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Children | Diabetes | Diabetes Type 1 | Endocrinology | Health | Insulin | Science | Universities & Medical Training | Yale